NSE filing, NSE: SPARC. Summary written from the filing by ALFA Finder's alert engine.
Sun Pharma Advanced Research Company Ltd: key numbers
- Share price
- ₹182.66
- Market cap
- ₹5,928 Cr
- Revenue (annual)
- ₹1,879 Cr
- Net profit (annual)
- ₹1,553 Cr
- P/E (TTM)
- 3.7×Sector 46.1×
- Promoter holding
- 65.67%+0.00% QoQ
- FII holding
- 3.74%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sun Pharma Advanced Research Company Ltd
All →Sun Pharma Advanced Research Company Board Meeting Date
SPARC intimated its Board will meet November 2, 2026 to consider Q1 and H1 FY27 unaudited results. Insider trading window stays closed until 48 hours post-declaration.
Sun Pharma Advanced Research Company Other Announcement
Sun Pharma Advanced Research Company Ltd has filed its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026.
Sun Pharma Advanced Research Company Legal & Regulatory
The company secured a favorable CESTAT order confirming its entitlement to a Rs. 27.51 Crore CENVAT credit refund. This concludes the litigation in the company's favor.
- Value
- ₹27.51 Cr
Sun Pharma Advanced Research Company Other Announcement
Sun Pharma Advanced Research Company Ltd has filed its quarterly shareholding pattern for the period ended June 30, 2026.
Sun Pharma Advanced Research Company Promoter Reclassification
Sun Pharma Advanced Research Company has submitted an application to stock exchanges to reclassify certain members from 'Promoter Group' to 'Public' category.
Sun Pharma Advanced Research Company Annual General Meeting
SPARC held its 21st Annual General Meeting on August 10, 2026, via video conferencing. The meeting covered routine business, including adoption of financial statements.
Other promoter reclassification announcements
All →Kkalpana Plastick Promoter Reclassification
Kkalpana Plastick reports promoters Bbigplas Poly and Sarla Surana reclassified to public after Ashish Begwani's open offer. Begwani, acquiring 40.12 lakh shares, becomes sole promoter.
Thirumalai Chemicals Promoter Reclassification
Thirumalai Chemicals received requests from two promoter group members, Narayan Santhanam and Deepa Ajay, to reclassify 100,000 shares (0.08%) as public. The board will consider the requests at its next meeting.
Star Health and Allied Insurance Company Promoter Reclassification
Star Health's board approved reclassifying Sthitaprajna Advisors LLP from promoter group to public shareholder category. The move is subject to requisite regulatory approvals.
SBI Funds Management Promoter Reclassification
SBI Funds Management's shareholding filing seeks Regulation 31A reclassification of Indian Digital Payment Intelligence Corporation from promoter group to public. No monetary value is involved.
GSPL Transmission Promoter Reclassification
GSPL Transmission received a request from promoter GSEG to reclassify its 0.14% stake from Promoter to Public category under Regulation 31A. Reclassification awaits Board and exchange approval.
BGR Energy Systems Promoter Reclassification
BGR Energy Systems received a Reg 31A reclassification request from promoter S.K. Sridhar to move 104 shares (0.0001%) from Promoter to Public category.